Computational Study of Trisindoline 5 Against Overexpressed EGFR Protein on Breast Cancer Stem Cell
The current treatment to control the proliferation rate of breast cancer is still not optimal due to the presence of breast cancer stem cells (BCSCs) which are resistant to several chemotherapy agents. Epidermal Growth Factor Receptor (EGFR) may promote the survival of BCSCs. The existing inhibitory...
Saved in:
Main Authors: | Nurhayati A.P.D., Fatoni M., Santoso M., Wati F.A. |
---|---|
Format: | Article |
Language: | English |
Published: |
EDP Sciences
2025-01-01
|
Series: | BIO Web of Conferences |
Online Access: | https://www.bio-conferences.org/articles/bioconf/pdf/2025/08/bioconf_srcm24_05010.pdf |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
EGFR Amplification and Glioblastoma Stem-Like Cells
by: Katrin Liffers, et al.
Published: (2015-01-01) -
Egfr Amplification Specific Gene Expression in Phyllodes Tumours of the Breast
by: Konstantin Agelopoulos, et al.
Published: (2007-01-01) -
EGFR-TKIs or EGFR-TKIs combination treatments for untreated advanced EGFR-mutated NSCLC: a network meta-analysis
by: Ao Liu, et al.
Published: (2024-11-01) -
Dual Functions of Androgen Receptor Overexpression in Triple-Negative Breast Cancer: A Complex Prognostic Marker
by: Umay Kiraz, et al.
Published: (2025-01-01) -
Correction: EGFR-TKIs or EGFR-TKIs combination treatments for untreated advanced EGFR-mutated NSCLC: a network meta-analysis
by: Ao Liu, et al.
Published: (2025-01-01)